Trinity Biotech (TRIB) Return on Equity (2021 - 2022)
Trinity Biotech recorded quarterly Return on Equity of 0.2% in Q4 2022, down 500.84% quarter-over-quarter from 0.03% in Q3 2022, and down 34.0% year-over-year from 0.3% in Q4 2021.
Trinity Biotech's Return on Equity history runs 2 years deep, the most recent figure standing at 0.2% for Q4 2022.
- In Q4 2022, Return on Equity fell 34.0% year-over-year to 0.2%; the TTM figure through Dec 2022 stood at 0.2% (down 34.0% YoY), while the FY2025 annual figure was 0.01%, up 1.0% from the prior year.
- Return on Equity came in at 0.2% for Q4 2022 at Trinity Biotech, down from 0.03% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 1.09% in Q3 2021 to a low of 0.83% in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -0.20% |
| Sep 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.05% |
| Mar 31, 2022 | 0.04% |
| Dec 31, 2021 | 0.14% |
| Sep 30, 2021 | 1.09% |
| Jun 30, 2021 | -0.83% |
| Mar 31, 2021 | -0.41% |